Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapyA pooled analysis of two randomized studies

被引:5
|
作者
Aristotle Bamias
George Basdanis
Ioannis Xanthakis
Nicholas Pavlidis
George Fountzilas
机构
[1] University of Athens,Dept of Clinical Therapeutics, Medical School
[2] Aristotle University of Thessaloniki,Medical School
[3] Ioannina University,Medical School
来源
关键词
Adjuvant therapy; colorectal cancer; prognostic factors; 5-FU;
D O I
10.1385/IJGC:36:1:029
中图分类号
学科分类号
摘要
Background. Although the TNM system is useful in predicting survival in resected colorectal cancer, heterogeneity within the same stages regarding prognosis exists. We are presenting a pooled analysis of prognostic factors from two randomized studies of adjuvant treatment conducted by the Hellenic Cooperative Oncology Group.
引用
收藏
页码:29 / 38
页数:9
相关论文
共 50 条
  • [21] Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
    Cassidy, James
    Saltz, Leonard B.
    Giantonio, Bruce J.
    Kabbinavar, Fairooz F.
    Hurwitz, Herbert I.
    Rohr, Ulrich-Peter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (05) : 737 - 743
  • [22] Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
    James Cassidy
    Leonard B. Saltz
    Bruce J. Giantonio
    Fairooz F. Kabbinavar
    Herbert I. Hurwitz
    Ulrich-Peter Rohr
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 737 - 743
  • [23] Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
    Hemminki, A
    Mecklin, JP
    Järvinen, H
    Aaltonen, LA
    Joensuu, H
    GASTROENTEROLOGY, 2000, 119 (04) : 921 - 928
  • [24] Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Osamu Togawa
    Hirofumi Kogure
    Yukiko Ito
    Keisuke Yamamoto
    Suguru Mizuno
    Hiroshi Yagioka
    Yoko Yashima
    Kazumichi Kawakubo
    Toshihiko Arizumi
    Saburo Matsubara
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Nobuo Toda
    Minoru Tada
    Masao Omata
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 847 - 853
  • [25] Voice of cancer patients: Analysis of concerns of patients receiving adjuvant chemotherapy for breast cancer
    Aggarwal, S.
    Liu, M.
    Sharma, R.
    Gupta, A.
    Singh, D.
    Sharma, R.
    Yang, F.
    Basak, A.
    Aggarwal, A.
    CANCER RESEARCH, 2016, 76
  • [26] Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Togawa, Osamu
    Kogure, Hirofumi
    Ito, Yukiko
    Yamamoto, Keisuke
    Mizuno, Suguru
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Arizumi, Toshihiko
    Matsubara, Saburo
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Toda, Nobuo
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 847 - 853
  • [27] Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
    Saisho, T
    Okusaka, T
    Ueno, H
    Morizane, C
    Okada, S
    HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1654 - 1658
  • [28] Prognostic factors and adjuvant chemotherapy efficacy in stage I gastric cancer patients: a retrospective analysis
    Xiao, Hua
    Li, Huiling
    Jian, Lian
    Ai, Zhaodong
    Hu, Pingsheng
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [29] OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    BASTARRACHEA, J
    HORTOBAGYI, GN
    SMITH, TL
    KAU, SWC
    BUZDAR, AU
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) : 18 - 25
  • [30] Prognostic Factors for Hyperglycemia in Patients Receiving Chemotherapy
    Kim, Jiyeong
    Lim, Kyung Hee
    CANCER NURSING, 2025, 48 (02) : 112 - 120